DMPK and myotonic dystrophy type 1: Following an extensive screening in cell lines derived from DM1 patients and DM300 mice, a (CAG)7 ASO with 2′-O-Me and PS backbone modifications has been shown to decrease DMPK transcripts in vitro by up to 90% [92].